MEI Pharma Inc (MEIP)
2.78
-0.03
(-1.07%)
USD |
NASDAQ |
Nov 22, 16:00
2.79
+0.01
(+0.36%)
Pre-Market: 20:00
MEI Pharma Free Cash Flow: -43.43M for Sept. 30, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
Date | Value |
---|---|
September 30, 2024 | -43.43M |
June 30, 2024 | -50.48M |
March 31, 2024 | -43.82M |
December 31, 2023 | -53.02M |
September 30, 2023 | -56.16M |
June 30, 2023 | -52.52M |
March 31, 2023 | -56.99M |
December 31, 2022 | -61.93M |
September 30, 2022 | -56.34M |
June 30, 2022 | -49.22M |
March 31, 2022 | -44.68M |
December 31, 2021 | -43.26M |
September 30, 2021 | -30.65M |
June 30, 2021 | -32.67M |
March 31, 2021 | 47.60M |
December 31, 2020 | 52.17M |
September 30, 2020 | 37.69M |
June 30, 2020 | 33.36M |
March 31, 2020 | -43.71M |
December 31, 2019 | -44.02M |
September 30, 2019 | -30.90M |
June 30, 2019 | -29.64M |
March 31, 2019 | -25.05M |
December 31, 2018 | -19.91M |
September 30, 2018 | -27.29M |
Date | Value |
---|---|
June 30, 2018 | -21.04M |
March 31, 2018 | -20.75M |
December 31, 2017 | -12.90M |
September 30, 2017 | -11.90M |
June 30, 2017 | 3.435M |
March 31, 2017 | 3.146M |
December 31, 2016 | -2.848M |
September 30, 2016 | -3.329M |
June 30, 2016 | -17.86M |
March 31, 2016 | -21.12M |
December 31, 2015 | -24.88M |
September 30, 2015 | -27.11M |
June 30, 2015 | -28.08M |
March 31, 2015 | -27.22M |
December 31, 2014 | -24.16M |
September 30, 2014 | -22.16M |
June 30, 2014 | -19.50M |
March 31, 2014 | -16.40M |
December 31, 2013 | -13.97M |
September 30, 2013 | -11.66M |
June 30, 2013 | -10.08M |
March 31, 2013 | -8.61M |
December 31, 2012 | -8.228M |
September 30, 2012 | -7.84M |
June 30, 2012 | -7.081M |
Free Cash Flow Range, Past 5 Years
-61.93M
Minimum
Dec 2022
52.17M
Maximum
Dec 2020
-29.60M
Average
-43.92M
Median
Free Cash Flow Benchmarks
Avid Bioservices Inc | -11.45M |
Evoke Pharma Inc | -5.325M |
Revance Therapeutics Inc | -194.91M |
NovaBay Pharmaceuticals Inc | -4.812M |
Palatin Technologies Inc | -32.57M |
Free Cash Flow Related Metrics
Cash from Operations (Quarterly) | -11.45M |
Cash from Investing (Quarterly) | 14.70M |
Free Cash Flow Per Share (Quarterly) | -1.718 |
Free Cash Flow Yield | -234.5% |